- Report
- January 2026
- 303 Pages
Global
From €5049EUR$5,850USD£4,388GBP
- Report
- January 2026
- 486 Pages
Global
From €5049EUR$5,850USD£4,388GBP
- Report
- December 2025
- 250 Pages
Global
From €3875EUR$4,490USD£3,368GBP
- Report
- November 2025
- 250 Pages
Global
From €3875EUR$4,490USD£3,368GBP
- Report
- October 2025
- 250 Pages
Global
From €3875EUR$4,490USD£3,368GBP
- Report
- September 2025
- 250 Pages
Global
From €3875EUR$4,490USD£3,368GBP
- Report
- September 2025
- 250 Pages
Global
From €3875EUR$4,490USD£3,368GBP
- Report
- April 2025
- 200 Pages
Global
From €3875EUR$4,490USD£3,368GBP
- Report
- April 2025
- 200 Pages
Global
From €3875EUR$4,490USD£3,368GBP
- Report
- February 2025
- 200 Pages
Global
From €3875EUR$4,490USD£3,368GBP
- Report
- January 2026
- 195 Pages
Global
From €3400EUR$3,939USD£2,955GBP
- Report
- October 2025
- 183 Pages
Global
From €3400EUR$3,939USD£2,955GBP
- Report
- August 2025
- 187 Pages
Global
From €3400EUR$3,939USD£2,955GBP
- Report
- August 2025
- 199 Pages
Global
From €3400EUR$3,939USD£2,955GBP
- Report
- May 2025
- 188 Pages
Global
From €3884EUR$4,500USD£3,376GBP
- Report
- February 2025
- 182 Pages
Global
From €3884EUR$4,500USD£3,376GBP
- Report
- September 2025
- 250 Pages
Global
From €3875EUR$4,490USD£3,368GBP
- Report
- September 2025
- 250 Pages
Global
From €3875EUR$4,490USD£3,368GBP
- Report
- January 2026
- 185 Pages
Global
From €3884EUR$4,500USD£3,376GBP
- Report
- February 2025
- 188 Pages
Global
From €3884EUR$4,500USD£3,376GBP

The Drug Discovery AI market is a rapidly growing sector of the pharmaceutical industry, focused on the development of artificial intelligence (AI) technologies to aid in the discovery of new drugs. AI-driven drug discovery is a process that uses machine learning algorithms to identify potential drug targets and develop new drug candidates. AI-driven drug discovery can reduce the time and cost of drug development, as well as improve the accuracy of drug discovery.
The Drug Discovery AI market is composed of a variety of companies, ranging from large pharmaceutical companies to small startups. Companies in the market include Atomwise, Exscientia, Insilico Medicine, and Recursion Pharmaceuticals. These companies are developing AI-driven drug discovery technologies to help accelerate the drug discovery process. Show Less Read more